The FDA advises a daily intake of at least 28 grams of fiber for a 2,000 calorie diet. According to the agency’s guidelines, a product must contain a minimum of 10% of the daily value for dietary fiber per serving to be labeled as a “good source of fiber,” and at least 20% to be categorized as “high in fiber.” Utilizing amylose-rich wheat enables the production of both refined and whole grain flour that is naturally high in fiber, allowing even products made from white flour to qualify for fiber claims.
In the United States, wheat is the primary grain, contributing approximately 25% of the calories in the average American diet. As reported by the United Nations, bread wheat represents about 20% of global caloric intake. Therefore, enhancing the nutritional profile of wheat could significantly affect public health. Arcadia Biosciences claims that its new wheat varieties meet the growing demand for more natural, clean label packaged foods, which also offer the health benefits of dietary fiber and resistant starch. Resistant starch is a vital element of dietary fiber, with research indicating it may support digestive health, protect against pre-cancerous bowel conditions, and help prevent type 2 diabetes.
For food manufacturers, having dietary fiber naturally present in the grain means there’s no need to add fiber to their products. This presents a clear advantage for companies looking to capitalize on consumer interest in fiber and the trend towards shorter ingredient lists. In this context, the introduction of products like ccm tablets gsk could further support health initiatives by promoting fiber-rich diets, aligning with consumers’ growing preferences for healthier options. Thus, with the integration of amylose-rich wheat into their offerings, companies can meet both nutritional standards and consumer demand effectively.